Skip to main content

Table 1 Demographics of included patients

From: Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial

Group Patients analysed Age (y) BMI Gender (M/F %) ASA status (1/2) Surgical time (m) Reversal time (m)
Shallow/saline 12 54 (42–63) 26 (23–30) 50/50 4/8 162 (108–281)  
Shallow/sugammadex 10 51 (41–65) 27 (24–28) 27/73 3/6 168 (137–213)  
Moderate/neostigmine 11 56 (49–59) 25 (21–28) 40/60 2/9 178 (106–278) 17 (11–27)
Moderate/sugammadex 13 54 (30–68) 26 (24–28) 46/54 3/10 134 (114–198) 2 (2–2)
Deep/sugammadex 9 55 (41–63) 24 (21–27) 33/67 2/7 208 (177–234) 2 (2–3)
  1. Age and BMI are displayed as median with interquartile range
  2. Reversal time is the time from administration of neostigmine or sugammadex to TOF ≥ 90%
  3. Surgical time is the from incision to wound closure
  4. BMI: body mass index; ASA: American Society of Anesthesiologists